IP Valuation of Gene Therapy Biotech Company

Healthcare

Instruction

AMCO was instructed by a biotechnology firm focused on gene therapy solutions to value its IP portfolio. The company needed an independent valuation for fundraising purposes as it prepared for clinical trials of its flagship treatment.

AMCO Process

AMCO Approach

We reviewed the firm’s patents, clinical trial data, and proprietary gene-editing technologies. Our valuation accounted for the therapy’s market potential, competitive landscape, and regulatory considerations within gene therapy.

Expected

Client Outcome

The robust IP valuation enabled the biotech firm to attract major investment, securing funding needed for clinical trials and advancing towards regulatory approval.

Contact

Get In Touch



    I consent to my data being used in accordance with the Privacy Policy.

    I consent to my personal data being collected and stored for the purpose of marketing communications


    Copyright © AMCO AGENCY LTD | All Rights Reserved | Website by Dentify Digital